Anne‐Sofie Schrohl

Author

Anne‐Sofie Schrohl

University of Copenhagen

Also Known As

A Schrohl, A.S. Schrohl, Anne-Sofie Schrohl, Anne‐Sofie Schrohl

Publications

949

Citations

H-Index

Concepts

All Affiliations

University of Copenhagen Technical University of Denmark Danish Breast Cancer Cooperative Group Rigshospitalet Erasmus MC

About

Anne‐Sofie Schrohl is an author at University of Copenhagen specializing in cancer therapeutics, breast cancer, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	18
2	Pathology	1	1	18
3	Cancer Therapeutics	1	1	18
4	Tumor Biology	1	1	18
5	Breast Cancer	1	1	18

Anne‐Sofie Schrohl

Publications

596

Citations

H-Index

Page 1

	Year	Citations
Tumor Tissue Levels of Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Marker in Primary Breast Cancer Anne‐Sofie Schrohl, Mads Holten-Andersen, Harry A. Peters, Clinical Cancer Research	2004	123
Primary Tumor Levels of Tissue Inhibitor of Metalloproteinases-1 Are Predictive of Resistance to Chemotherapy in Patients with Metastatic Breast Cancer Anne‐Sofie Schrohl, Marion E. Meijer‐van Gelder, Mads Holten-Andersen, Clinical Cancer Research	2006	74
Tumor Tissue Concentrations of the Proteinase Inhibitors Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and Plasminogen Activator Inhibitor Type 1 (PAI-1) Are Complementary in Determining Prognosis in Primary Breast Cancer Anne‐Sofie Schrohl, Ib Jarle Christensen, Anders N. Pedersen, Molecular & Cellular Proteomics	2003	71
Plasma levels of the MMP-9:TIMP-1 complex as prognostic biomarker in breast cancer: a retrospective study Stine Buch Thorsen, Sarah Louise Christensen, Sidse Ørnbjerg Würtz, BMC Cancer	2013	54
Human epidermal growth factor receptor 2 (HER2) immunoreactivity: specificity of three pharmacodiagnostic antibodies Anne‐Sofie Schrohl, Hans Christian Pedersen, Sussie Steen Jensen, Histopathology	2011	47
Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines Haatisha Jandu, Kristina Aluzaite, Louise Fogh, BMC Cancer	2016	46
Acquisition of docetaxel resistance in breast cancer cells reveals upregulation of ABCB1 expression as a key mediator of resistance accompanied by discrete upregulation of other specific genes and pathways Stine Hansen, David Westergaard, Mathilde Borg Houlberg Thomsen, Tumor Biology	2015	42
TIMP-1 Increases Expression and Phosphorylation of Proteins Associated with Drug Resistance in Breast Cancer Cells Omid Hekmat, Stephanie Munk, Louise Fogh, Journal of Proteome Research	2013	37
The stepwise evolution of the exome during acquisition of docetaxel resistance in breast cancer cells Stine Hansen, Natasja Ehlers, Shida Zhu, BMC Genomics	2016	33
Tumor tissue levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and outcome following adjuvant chemotherapy in premenopausal lymph node-positive breast cancer patients: A retrospective study Anne‐Sofie Schrohl, Maxime P. Look, Marion E. Meijer‐van Gelder, BMC Cancer	2009	20

Page 1